Effects of long-term estrogen replacement therapy. I. Metabolic effects

American Journal of Obstetrics and Gynecology

Volumn 133, Issue 5, 1979, Pages 525-536

  Hammond, Charles B ^a   Jelovsek, Frederick R ^a   Lee, Kerry L ^a   Creasman, William T ^a   Parker, Roy T ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; CARDIAC AGENT; CONJUGATED ESTROGEN; ESTROGEN; PROGESTERONE; TRANQUILIZER;

ADVERSE DRUG REACTION; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; ENDOMETRIUM CANCER; HYPERTENSION; HYPOESTROGENISM; MAJOR CLINICAL STUDY; MENSTRUAL IRREGULARITY; OSTEOPOROSIS; PREVENTION; PREVENTIVE MEDICINE; THERAPY;

AGE FACTORS; AMENORRHEA; ANTHROPOMETRY; BIOLOGY; BLEEDING; BODY WEIGHT; CANCER; CARDIOVASCULAR EFFECTS; CHILD DEVELOPMENT; CLINICAL RESEARCH; CULTURAL BACKGROUND; DEMOGRAPHIC FACTORS; DEPRESSION; DISEASES; ENDOCRINE SYSTEM; ENDOMETRIAL CANCER; ENDOMETRIAL EFFECTS; ENDOMETRIUM; EPIDEMIOLOGIC METHODS; ESTROGENS--INDICATIONS; ESTROGENS--SIDE EFFECTS; ETHNIC GROUPS; FERTILITY; FERTILITY MEASUREMENTS; GENITALIA; GENITALIA, FEMALE; GROWTH; HORMONES; HYPERTENSION; LONGTERM EFFECTS; MARITAL STATUS; MENSTRUATION DISORDERS; MENTAL DISORDERS; NEOPLASMS; NUPTIALITY; PARITY; PHYSIOLOGY; POPULATION; POPULATION CHARACTERISTICS; POPULATION DYNAMICS; RESEARCH METHODOLOGY; SIGNS AND SYMPTOMS; TIME FACTORS; UROGENITAL SYSTEM; UTERUS; VASCULAR DISEASES;

ADENOCARCINOMA; ADULT; CARDIOVASCULAR DISEASES; CASTRATION; ENDOCRINE SYSTEM DISEASES; ESTROGENS; FEMALE; FRACTURES, BONE; GASTROINTESTINAL DISEASES; HUMANS; HYPOGONADISM; MENTAL DISORDERS; MIDDLE AGED; NORTH CAROLINA; OSTEOPOROSIS; TURNER SYNDROME; UROLOGIC DISEASES; UTERINE NEOPLASMS;

EID: 0018379584     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9378(79)90288-6     Document Type: Article

References (31)

1. Intensive steroid and hormone profiles on post-menopausal women experiencing hot flushes, and a group of controls
2. The menopause
3. Prevention of postmenopausal osteoporosis by hormone treatment of the menopause
4. The development of elevated blood pressure while using oral contraceptives
5. Contraindications to estrogen therapy and management of the menopausal syndrome
6. The urethnal pressure profile: Theoretical considerations and clinical application
7. The effects of natural oestrogen replacement therapy on menopausal symptoms and blood clotting
8. Non-Genital Target Tissues of Estrogens
9. Psychochormonal approach to the menopause
10. Estrogen and endometrial cancer in a retirement community
11. Association of exogenous estrogen and endometrial carcinoma
12. Increased rise of endometrial carcinoma among users of conjugated estrogens
13. Increasing incidence of endometrial cancer in the United States
14. Exogenous estrogen and endometrial carcinoma: Case-control and incidence study
15. Effects of long-term estrogen therapy. II. Neoplastic effects
16. Statistical aspects of the analysis of data from retrospective studies of disease
17. Coronary risk factors
18. Ovarian function and atherosclerosis
19. The results of estrogen treatment in one thousand hysterectomized women for 14,318 years
20. The two clinical features of postmenopause and oophorectomy and their response to oestrogen therapy
21. Myocardial infarction and estrogen therapy in post-menopausal women
22. Reproductive steroids and the circulatory system
23. Report from the Boston Collaborative Drug Surveillance Program
24. Metabolic effects of oral contraceptives
25. The effect of synthetic and natural estrogens on glucose tolerance, plasma insulin and lipid metabolism in postmenopausal women
26. The fate of non-treated postmenopausal women: A plea for the maintenance of adequate estrogen from puberty to the grave
27. Administration of estrogens to older women, a psychosomatic evaluation
28. Clinical significance and pathogenesis of osteoporosis
29. Current status of menopause and postmenopausal estrogen therapy
30. Osteoporosis after oophorectomy for non-malignant disease in premenopausal women